FID-007 in Treating Participants With Advanced Solid Tumors
Conditions: Advanced Malignant Solid Neoplasm; Refractory Malignant Solid Neoplasm Interventions: Other: Laboratory Biomarker Analysis; Drug: PEOX-based Polymer Encapsulated Paclitaxel FID-007; Other: Pharmacokinetic Study Sponsors: University of Southern California; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Study